Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 1
2(40.0%)
5Total
N/A(3)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05462223Not ApplicableRecruiting

Alucent Vessel Restoration System for AVF

Role: lead

NCT05455021Not ApplicableActive Not Recruiting

Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) After Sub-optimal Percutaneous Transluminal Angioplasty (PTA) or Atherectomy: REACTIVATE I

Role: lead

NCT05454995Not ApplicableActive Not Recruiting

Feasibility Study of the Vessel Restoration System (VRS): ACTIVATE II

Role: lead

NCT04188262Phase 1Completed

Natural Vascular Scaffold (NVS) Therapy for Treatment of Atherosclerotic Lesions (Activate I)

Role: lead

NCT03148808Phase 1Completed

Natural Vascular Scaffold (NVS) Therapy

Role: lead

All 5 trials loaded